Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + S-1 vs Bevacizumab + Capecitabine as Maintenance in Advanced Colorectal Adenocarcinoma
NCT03708536Phase 3Withdrawn
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Nov 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in colorectal adenocarcinoma, sponsored by Fujian Medical University Cancer Hospital. Planned start Nov 2018; status: withdrawn.
02
Drugs
tegafur
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT03708536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03708536.